Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

Summary

This is a prospective, single arm phase II study to evaluate the efficacy and safety of fulvestrant as a maintenance hormone therapy after first-line chemotherapy for postmenopausal HR positive advanced breast cancer.

Timeline

Start

2013-11

Primary completion

2016-04

Completion

2018-12

Drugs

Indications